Madrigal Pharmaceuticals

MDGL | NASDAQ | 0 Followers
$314.64 +1.96% $6.05
Follow
Overview Metrics Financials
Loading...

Fair Price

$402.61
Undervalued by 57.6%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Madrigal Pharmaceuticals, Inc. is an American biotechnology company focused on developing new therapeutic drugs for liver and cardiometabolic diseases. The company specializes in research and development of drugs aimed at improving liver health, particularly in relation to non-alcoholic steatohepatitis (NASH) and cirrhosis. Madrigal Pharmaceuticals is known for its innovative technology targeting selective activation of liver receptors, which has the potential to provide effective therapeutic options for patients suffering from these complex and difficult-to-treat conditions.

Feed

7M
Read More

Madrigal Pharmaceuticals: a leader in MASH treatment with significant growth potential

Madrigal Pharmaceuticals $MDGL entered 2024 with significant success when it launched its first approved drug, Rezdiffra, for the treatment of metabolic steatohepatitis (MASH). This unique drug helps patients with moderate to advanced liver fibrosis, giving Madrigal a privileged position in a...
Read more
3
Share
Zobrazit další komentáře

I read now that Trump has appointed a new Health Secretary and he is not supporting and fighting against such companies, so we'll see how this plays out now.
Like 0
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade